What is the dose of Avil (pheniramine) in anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Avil (Pheniramine) Has No Role in Anaphylaxis Treatment

Pheniramine (Avil) should NOT be used in anaphylaxis—epinephrine is the only first-line treatment and must be administered immediately. Antihistamines like pheniramine are adjunctive therapy only for cutaneous symptoms and should never be given before or instead of epinephrine. 1

Why Antihistamines Are Not Appropriate First-Line Treatment

Antihistamines do not address the life-threatening manifestations of anaphylaxis:

  • Antihistamines cannot relieve or prevent airway obstruction, hypotension, or shock—the primary causes of death in anaphylaxis 2
  • They have a delayed onset of action, reaching maximal plasma concentrations in 1-3 hours compared to <10 minutes for intramuscular epinephrine 2
  • Histamine is only one of multiple mediators released during anaphylaxis; blocking histamine receptors alone is insufficient 1, 2

Correct First-Line Treatment: Epinephrine

Administer epinephrine immediately upon recognition of anaphylaxis:

  • Dose: 0.01 mg/kg of 1:1000 (1 mg/mL) solution intramuscularly, up to maximum 0.5 mg in adults and 0.3 mg in children 1, 3
  • Route: Intramuscular injection into the anterolateral thigh (vastus lateralis) 1, 3
  • Repeat dosing: Every 5-15 minutes if symptoms persist 1, 3
  • No absolute contraindications to epinephrine use in anaphylaxis 1

When Antihistamines May Be Used (As Adjunctive Therapy Only)

After epinephrine administration, antihistamines may help with cutaneous symptoms:

  • H1-antihistamines: Diphenhydramine 25-50 mg IV/IM (1-2 mg/kg in children) for urticaria and pruritus 3, 4
  • H2-antihistamines: Ranitidine 50 mg IV for adults (1 mg/kg for children) may be considered 3, 4
  • These should only be given after epinephrine and do not replace it 1, 5

Critical Pitfalls to Avoid

Common errors that endanger patients:

  • Never delay epinephrine to administer antihistamines—delayed epinephrine is associated with fatalities 5, 2
  • Never substitute antihistamines or bronchodilators for epinephrine 5, 6
  • Antihistamines do not prevent biphasic reactions despite common misconceptions 6
  • Chlorpheniramine (a related antihistamine) can itself rarely cause anaphylaxis 7

Complete Anaphylaxis Management Algorithm

After epinephrine administration:

  1. Position patient supine with legs elevated (unless respiratory distress present) 3, 5
  2. Administer IV fluids: 500-1000 mL crystalloid bolus for adults, 20 mL/kg for children 3
  3. Provide supplemental oxygen and monitor vital signs continuously 3, 5
  4. For persistent bronchospasm: Albuterol nebulization 2.5-5 mg after epinephrine 3
  5. For refractory hypotension: Consider epinephrine infusion 5-15 μg/min 3
  6. Observe minimum 6 hours for potential biphasic reactions 3, 5, 4

Second-line adjunctive medications (after epinephrine):

  • Corticosteroids: Methylprednisolone 1-2 mg/kg IV or prednisone 0.5 mg/kg orally to potentially prevent biphasic reactions 3
  • These provide no acute benefit and should not delay epinephrine 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylaxis Management in Sugammadex-Induced Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylaxis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Emergency medicine updates: Anaphylaxis.

The American journal of emergency medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.